SCHEMBL8068427

SCHEMBL8068427

CC(C)(C)OC(=O)Nc1ccc(-c2ccccc2)nc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 17/20 0.59
HDAC3 O15379 10/20 0.58
HDAC2 Q92769 10/20 0.58
KCNH2 Q12809 1/20 0.58
HDAC8 Q9BY41 9/20 0.58
HDAC4 P56524 8/20 0.58
HDAC7 Q8WUI4 8/20 0.58
HDAC10 Q969S8 8/20 0.58
HDAC11 Q96DB2 8/20 0.58
HDAC6 Q9UBN7 8/20 0.58
HDAC9 Q9UKV0 8/20 0.58
HDAC5 Q9UQL6 8/20 0.58
KDM1A O60341 2/20 0.57
CYP3A4 P08684 1/20 0.57
F3 P13726 1/20 0.57
NCOR2 Q9Y618 1/20 0.57
NAMPT P43490 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8082841 0.93 HDAC1 (0.52) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL3640161 0.90 HDAC1 (0.64) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL8075188 0.89 HDAC1 (0.61) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL16168325 0.89 HDAC1 (0.56) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL3642860 0.87 HDAC1 (0.57) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL1435252 0.86 HDAC1 (0.74) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL8113197 0.86 HDAC1 (0.75) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL3771406 0.85 HDAC1 (0.56) HDAC1HDAC3HDAC2KCNH2HDAC8
SCHEMBL3648233 0.85 HDAC1 (0.54) HDAC1HDAC3HDAC2HDAC6NAMPT
SCHEMBL3649530 0.85 HDAC1 (0.53) HDAC1HDAC3HDAC2KCNH2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461189-B2 Pyridyl derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
US-8461189-B2 Pyridyl derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed
WO-2009005638-A2 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK & CO., INC. (US) 2009-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS BRDT, HDAC5, HDAC1 HDAC1 3/4885HDAC3 5/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.